News Releases
  Releases on AIM
  Most Recent Reports
   
   
Releases on AIM
Bodisen Biotech, Inc. (ˇ°Bodisenˇ± or the ˇ°Companyˇ±) Directorate Change


The Company announces that David Gatton has stepped down from his role as a Non-executive
Director of the Company with immediate effect.


Enquiries:
Charles Stanley Securities (Nominated Adviser)
Rick Thompson 0207 149 6000


Copyright © 2004 bodisen.com